Elizabeth J Shpall

This inventor holds 11 USPTO granted patents and 29 published patent applications and 2 EPO patents. Top assignee: The University of Texas System. Active years: 2014-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Elizabeth J Shpall. Retrieved from https://idiyas.com/inventor/elizabeth-j-shpall

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 (Patent Applications = 29)

% Patents Active = 100.0

EPO Patents = 2 (Patent Applications = 29)

Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 7(Granted Patents)

Company Filing History:

11 out of 5,638

The University of Texas System

patents

Years Active: 2014-2026

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12516100 - METHODS FOR PRODUCING REGULATORY B CELLS AND USES THEREOF (2026-01-06),

2. 12473336 - Methods for activation and expansion of natural killer cells and uses thereof (2025-11-18),

3. 12466867 - Methods for activation and expansion of natural killer cells and uses thereof (2025-11-11),

4. 12403093 - Methods for production of MSC-derived exosomes (2025-09-02),

5. 11766402 - Methods for production of MSC-derived exosomes (2023-09-26),

6. 11344578 - Immune cells expressing engineered antigen receptors (2022-05-31),

7. 11154572 - Methods of treatment with natural killer cells matched for killer immunoglobulin receptor type (2021-10-26),

8. 10821134 - BK virus specific T cells (2020-11-03),

9. 9993537 - [object Object] (2018-06-12),

10. 9333248 - Methods and composition related to Th-1 dendritic cells (2016-05-10),

11. 8728806 - [object Object] (2014-05-20),

Title: Innovations by Elizabeth J Shpall

Introduction

Elizabeth J Shpall is a prominent inventor based in Houston, TX (US). She has made significant contributions to the field of medical research, particularly in cancer treatment and regenerative medicine. With a total of 11 patents, her work has the potential to impact numerous lives.

Latest Patents

Among her latest patents are "Methods for activation and expansion of natural killer cells and uses thereof." This patent outlines methods for pre-activating and expanding an isolated population of NK cells, which can be utilized in cancer treatment. Another notable patent is "Methods for production of MSC-derived exosomes," which details the manufacturing of clinical-grade exosomes derived from mesenchymal stem cells (MSCs). This patent also includes methods for loading these exosomes with therapeutic agents, such as siRNA, and discusses their application in treating various diseases.

Career Highlights

Elizabeth J Shpall is affiliated with the University of Texas System, where she continues to advance her research and innovations. Her work is characterized by a commitment to improving therapeutic strategies and enhancing patient outcomes.

Collaborations

She has collaborated with notable colleagues, including Katy Rezvani and William K Decker, to further her research initiatives and expand the impact of her inventions.

Conclusion

Elizabeth J Shpall's contributions to medical research through her patents and collaborations highlight her role as an influential inventor in the field. Her innovative approaches to cancer treatment and regenerative medicine are paving the way for future advancements.

Profile summary based on public USPTO records.